Loopbaan van Gregory R. Cox
Eerdere bekende functies van Gregory R. Cox
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
DENDREON CORPORATION | Financieel Directeur/CFO | 26-02-2015 | 10-06-2015 |
Treasurer | 26-02-2015 | 10-06-2015 | |
DENDREON CORPORATION | Financieel Directeur/CFO | 10-10-2013 | 23-02-2015 |
Corporate Officer/Principal | 01-11-2005 | 10-10-2013 | |
Treasurer | 10-10-2013 | 23-02-2015 | |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Treasurer | 01-01-1995 | 01-09-2005 |
Opleiding van Gregory R. Cox
Otterbein College | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 4 |
Operationeel
Treasurer | 3 |
Director of Finance/CFO | 2 |
Corporate Officer/Principal | 1 |
Sectoraal
Health Technology | 3 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Health Technology |
Dendreon Corp.
Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |
- Beurs
- Insiders
- Gregory R. Cox
- Ervaring